|
CNTX Context Therapeutics Inc 1842952 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-8,680,572.00 |
| Balance Sheet |
|
Current Assets
|
$58,516,816.00 |
|
Assets
|
$58,859,093.00 |
|
Current Liabilities
|
$6,534,349.00 |
|
Liabilities
|
$6,656,718.00 |
|
Equity
|
$52,202,375.00 |
|
Shares Out
|
91879177.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-11,429,374.00 |
|
Investing Cash Flow
|
$-37,258.00 |
| Market Analysis |
Market Cap
|
$56,046,297.97 |
|
Price
|
$0.61 |
|
BVPS
|
0.57 |
|
PB
|
1.07 |
|
EPS
|
-0.09 |
|
FCF
|
$-11,466,632.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:40 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:39 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CNTX documents filed with the SEC.
CNTX Filings
Clear
